A Unique Approach to Predicting SCD
Sudden cardiac death (SCD) is the sudden, unexpected death of an individual with cardiovascular disease due to an arrhythmia. About 300,000-450,000 US patients die of SCD annually; millions more are at-risk.
Patients deemed at high risk for SCD are fitted with an Implantable Cardioverter Defibrillator (ICD), a small device that delivers an electric pulse or shock when it detects an arrhythmia, but there is no reliable clinical or diagnostic measure to identify people at high SCD risk. Therefore, ICD implantation is not well matched with patient risk. Many individuals at high risk of SCD do not receive ICD implants, and conversely some patients who receive the device do not use it. 3PrimeDx seeks to address this unmet medical need with the development of the PulsePredic™ test.
PulsePredic™ is a simple blood test that can accurately predict risk of SCD in at-risk individuals. It can improve the identification and selection of patients who need an ICD. Patients, doctors and insurance companies would benefit from PulsePredic™ by personalizing ICD implantation.